Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.90 |
| ▸ | CA2 | P00918 | 15/20 | 0.90 |
| ▸ | CA12 | O43570 | 13/20 | 0.90 |
| ▸ | CA9 | Q16790 | 13/20 | 0.90 |
| ▸ | CA4 | P22748 | 7/20 | 0.90 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8071460 | 1.00 | CA1 (0.90) | CA1CA2CA12CA9CA4 | |
| SCHEMBL23922194 | 0.90 | CA1 (0.90) | CA1CA2CA12CA9CA4 | |
| SCHEMBL2282260 | 0.86 | CA1 (0.88) | CA1CA2CA12CA9CA4 | |
| SCHEMBL2281606 | 0.85 | CA1 (0.77) | CA1CA2CA12CA9CA4 | |
| SCHEMBL15148345 | 0.84 | CA1 (0.82) | CA1CA2CA12CA9CA4 | |
| SCHEMBL20788644 | 0.83 | CA1 (0.76) | CA1CA2CA12CA9CA4 | |
| SCHEMBL21768241 | 0.83 | CA1 (0.77) | CA1CA2CA12CA9CA4 | |
| SCHEMBL2283991 | 0.82 | CA1 (0.74) | CA1CA2CA12CA9CA4 | |
| SCHEMBL10268864 | 0.80 | CA1 (0.66) | CA1CA2CA12CA9CA4 | |
| SCHEMBL594922 | 0.79 | CA1 (0.74) | CA1CA2CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0765331-B1 | OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES | AVECIA LTD (GB) | 2000-08-09 | — | — | EP | disclosed |
| US-5880188-A | PROTECTING MEDIUM SUSCEPTIBLE TO MICROBIAL ATTACK BY TREATING WITH SPECIFIED OXABOROLE COMPOUND | ZENECA LIMITED (GB) | 1999-03-09 | — | — | US | disclosed |